This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_PENIS_EXALLC for full statistics.
Malignant neoplasm of penis
C3_PENIS
penile neoplasm: Cancers or tumors of the PENIS or of its component tissues.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
116 |
4. Check minimum number of eventsNone |
116 |
5. Include endpointsNone |
116 |
6. Filter based on genotype QC (FinnGen only) |
116 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of penis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 116 | - | 116 |
| Unadjusted period prevalence (%) | 0.05 | - | 0.05 |
| Median age at first event (years) | 65.60 | - | 65.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 112
- Matched controls
- 1120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
94.6
77
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
57.3
50
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
51.0
45
*
PJA12
NOMESCO Finland
Sentinel node biopsy
153.4
46.0
46
5
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
38.8
35
*
KGB00
NOMESCO Finland
Biopsy of penis
+∞
38.8
35
*
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
37.6
34
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
35.3
32
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
424.3
32.6
31
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
30.6
28
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
40.0
28.9
36
13
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
23.8
22
*
KGD05
NOMESCO Finland
Partial excision of body of penis
+∞
22.7
21
*
KGH10
NOMESCO Finland
Operation for phimosis
19.8
21.6
33
23
N48.1
ICD-10 Finland
Balanoposthitis
25.5
20.9
29
15
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
+∞
18.2
17
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
16.6
17.9
29
23
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
106.1
17.1
18
*
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
+∞
14.9
14
*
KGD96
NOMESCO Finland
Other partial excision of penis
171.3
14.8
15
*
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
145.5
12.7
13
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
30.7
12.4
16
6
KDH10
NOMESCO Finland
Meatoplasty of urethra
+∞
10.6
10
*
WX402
NOMESCO Finland
General anaesthesia
5.2
10.5
36
94
TKD00
NOMESCO Finland
Dilatation of urethra
24.2
9.6
13
6
KGC10
NOMESCO Finland
Total amputation of penis
+∞
9.5
9
*
JN4BD
NOMESCO Finland
Extensive body CT
4.7
9.4
35
99
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
54.3
8.8
10
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
97.0
8.5
9
*
WX240
NOMESCO Finland
Penis blockade
97.0
8.5
9
*
D07.4
ICD-10 Finland
Carcinoma in situ: Penis
+∞
8.4
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.1
7.5
24
57
8051/3-C60.9
ICD-O-3
Verrucous carcinoma, NOS, of penis, NOS
+∞
7.4
7
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
7.4
7
*
N35.9
ICD-10 Finland
Urethral stricture, unspecified
18.1
6.9
10
6
KGD10
NOMESCO Finland
Destruction of lesion of penis
24.2
6.8
9
*
ZZA00
NOMESCO Finland
Split skin graft
8.2
6.6
14
19
UKC02
NOMESCO Finland
Cystoscopy
3.1
6.6
44
194
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
73.8
6.5
7
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
19.3
6.4
9
5
N48.8
ICD-10 Finland
Other specified disorders of penis
28.4
6.3
8
*
8070/3-C60.0
ICD-O-3
Squamous cell carcinoma, NOS, of prepuce
+∞
6.3
6
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
+∞
6.3
6
*
JN4AD
NOMESCO Finland
Body CT examination
4.5
6.2
22
58
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
6.2
46
216
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
8.8
6.0
12
15
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768795) Lymph node Pathology biopsy report
16
11
16.71
17.97
1.1
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
38
105
4.89
13.41
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
110
4.65
12.58
2.0
1.9
—
—
—
0
0
(4035726)
32
81
5.07
12.46
1.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
67
329
3.45
9.87
3.5
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
409
3.49
9.53
5.2
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
32
6.05
8.99
1.9
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
87
548
3.35
7.68
5.6
4.1
e6/l
24.2
6712.7
—
5
11
(3026008) Bacteria identified in Urine by Culture
46
209
2.99
7.26
3.0
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
43
206
2.73
5.98
1.7
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
55
306
2.52
5.56
3.2
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
33
153
2.62
4.77
2.3
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
42
224
2.37
4.48
3.2
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
53
320
2.21
4.16
5.1
4.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
90
679
2.45
4.01
10.7
8.4
u/l
77.3
81.3
0.45
85
643
(3032080) INR in Blood by Coagulation assay
63
420
2.09
3.72
11.9
8.7
inr
1.3
1.3
0.25
14
113
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
47
3.25
3.55
8.0
7.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
63
437
1.97
3.17
9.0
7.5
mmol/l
1.2
1.2
0.49
52
368
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
112
2.31
2.92
2.4
3.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
53
362
1.85
2.67
4.9
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
163
2.04
2.58
1.7
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
83
2.38
2.57
1.2
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
38
240
1.87
2.41
4.5
3.9
%
84.8
83.5
0.10
38
235
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
161
1.97
2.33
3.6
2.9
e6/l
0.7
0.5
0.30
18
89
(3037467) Urinalysis macro (dipstick) panel - Urine
74
577
1.78
2.28
5.9
4.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
55
2.54
2.21
1.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
23
129
1.98
2.04
2.7
2.5
%
1.6
1.7
0.67
23
115
(3004789) Transferrin [Mass/volume] in Serum or Plasma
26
153
1.90
2.01
3.1
2.6
g/l
2.1
2.2
0.53
26
138
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
95
814
1.92
1.97
23.9
15.9
ml/min/173m2
78.6
77.1
0.24
86
692
(36304419) Bacteria [Presence] in Urine
39
266
1.70
1.86
3.4
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
60
2.31
1.86
1.7
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
82
681
1.70
1.80
27.4
20.9
%
14.0
13.9
0.14
82
665
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
90
2.04
1.76
5.4
6.9
mmol/l
1.0
1.4
2.75
17
85
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
30
2.79
1.76
1.5
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
43
305
1.65
1.76
7.7
5.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
33
219
1.71
1.72
1.3
1.6
nmol/l
17.7
19.2
0.31
28
186
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
27
170
1.77
1.69
3.7
2.5
e6/l
1.8
1.1
0.45
18
98
(3018418) pH of Serum or Plasma
36
246
1.67
1.69
5.1
4.6
ph
7.4
7.4
—
8
46
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
48
356
1.59
1.62
2.1
2.0
pmol/l
86.5
90.3
0.19
30
209
(3019225) pH of Specimen
17
93
1.97
1.62
7.1
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
97
854
1.83
1.61
26.5
17.1
mg/l
31.3
28.4
0.45
92
714
(3030467) Casts [#/volume] in Urine by Automated count
40
286
1.61
1.56
3.9
2.9
e6/l
0.5
0.4
0.08
34
218
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
15
3.43
1.54
1.4
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
37
2.55
1.52
1.8
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
34
235
1.63
1.51
3.7
3.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
16
3.22
1.45
1.4
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
16
3.22
1.45
1.4
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
16
3.22
1.45
1.4
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
17
3.02
1.37
1.4
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
17
3.02
1.37
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
17
3.02
1.37
1.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
117
1.75
1.28
1.6
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
36
2.31
1.27
1.7
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
25
2.47
1.26
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
98
884
1.70
1.24
21.3
16.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
19
2.70
1.23
1.6
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
88
1.81
1.18
1.3
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
100
911
1.71
1.16
31.3
20.3
umol/l
91.6
91.4
0.02
100
911
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
20
2.56
1.16
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
28
197
1.56
1.14
1.8
1.7
nmol/l
1060.5
1184.2
0.35
22
154
(3013650) Neutrophils [#/volume] in Blood by Automated count
61
506
1.43
1.10
14.2
9.9
e9/l
4.9
4.5
0.59
56
434
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
21
2.44
1.10
1.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
21
2.44
1.10
1.0
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
15
91
1.74
1.06
8.2
8.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
22
2.33
1.04
1.4
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
36
275
1.45
0.99
7.3
3.6
mmol/l
2.4
2.3
1.45
31
243
(3021589) Normoblasts [#/volume] in Blood
49
397
1.41
0.98
12.6
11.0
e9/l
0.0
0.0
0.43
42
316
(3026782) Osmolality of Urine
30
222
1.47
0.97
3.1
3.0
mosm/kgh2o
601.7
611.2
0.09
25
190
(3021601) Nitrite [Presence] in Urine by Test strip
51
418
1.39
0.95
5.6
4.8
estimate
0.0
0.0
—
9
88
(3013512) EKG study
38
297
1.42
0.92
3.8
4.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
120
1.59
0.92
1.7
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
72
629
1.38
0.89
3.9
4.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
14
88
1.67
0.89
2.9
2.4
g/l
67.4
66.7
0.10
14
79
(3019150) Specific gravity of Urine by Refractometry
24
175
1.47
0.83
3.8
4.2
kg/l
1.0
1.0
—
10
26
(3009261) Glucose [Presence] in Urine by Test strip
51
427
1.35
0.81
3.9
3.6
estimate
0.0
0.0
—
9
80
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.86
0.80
2.2
2.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
50
418
1.34
0.80
3.9
3.6
estimate
0.0
0.0
—
9
85
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
23
2.22
0.77
1.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
40
326
1.35
0.74
4.4
4.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
39
1.84
0.74
1.1
2.4
u/l
31.9
38.5
—
7
34
(3028026) IgM [Mass/volume] in Serum or Plasma
9
57
1.63
0.73
2.1
1.6
g/l
1.0
1.2
—
9
51
(3037756) Immunofixation for Serum or Plasma
5
27
1.89
0.69
1.8
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
29
1.76
0.64
2.0
1.4
—
0.1
—
0
8
(3049717) Cytology report of Urine Cyto stain
8
50
1.64
0.63
2.0
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
30
1.70
0.62
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
71
640
1.28
0.60
3.4
3.9
mm/h
14.9
12.3
0.68
66
589
(3009542) Hematocrit [Volume Fraction] of Blood
80
733
1.29
0.59
25.6
17.7
%
39.2
40.4
0.42
52
504
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
23
0.00
0.59
0.0
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
51
443
1.27
0.58
8.1
6.1
e9/l
1.9
1.7
0.11
44
382
(3013115) Eosinophils [#/volume] in Blood
51
444
1.27
0.57
8.5
6.3
e9/l
0.3
0.2
0.53
45
380
(3007461) Platelets [#/volume] in Blood
99
936
1.39
0.56
36.6
24.7
e9/l
232.8
227.9
0.31
99
913
(3024731) MCV [Entitic volume]
99
936
1.39
0.56
36.5
24.6
fl
92.2
91.6
0.66
99
924
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
74
1.54
0.55
1.5
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
424
0.78
0.55
2.9
3.1
ug/l
0.8
0.8
0.05
24
281
(3026361) Erythrocytes [#/volume] in Blood
99
937
1.39
0.55
36.6
24.6
e12/l
4.4
4.6
1.66
99
911
(3035941) MCH [Entitic mass]
99
937
1.39
0.55
36.4
24.6
pg
30.6
30.6
0.04
99
925
(3000963) Hemoglobin [Mass/volume] in Blood
99
937
1.39
0.55
36.7
24.8
g/l
132.7
138.4
2.28
99
924
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
99
0.58
0.54
6.2
11.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
50
436
1.26
0.54
8.1
6.0
e9/l
0.0
0.0
0.46
43
369
(3001604) Monocytes [#/volume] in Blood
50
437
1.25
0.53
8.2
5.9
e9/l
0.7
0.6
1.34
43
368
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
110
1.42
0.52
1.4
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
122
1.36
0.45
5.0
4.6
%
28.8
30.1
0.18
11
82
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
12
87
1.42
0.44
2.0
2.2
g/l
0.2
0.2
0.02
12
79
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
32
1.59
0.43
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
5
33
1.54
0.42
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
16
0.00
0.41
0.0
1.8
—
68.5
—
0
16
(3000764) Benzodiazepines [Presence] in Urine
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
35
1.45
0.40
3.0
4.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
17
210
0.78
0.37
1.6
1.8
pmol/l
455.2
403.3
0.38
17
181
(3000494) Fungus identified in Specimen by Culture
14
108
1.34
0.37
2.0
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
24
284
0.80
0.37
2.5
2.1
nmol/l
70.1
73.7
0.28
19
247
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
41
1.49
0.36
1.5
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
43
1.42
0.35
5.5
2.4
—
1.3
—
0
6
(36660697) Celiac disease serology panel - Serum
6
46
1.32
0.33
1.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
89
848
1.21
0.33
4.6
4.8
mmol/l
6.2
6.2
0.02
81
765
(1761868) Lipid panel - Serum or Plasma
27
310
0.83
0.31
3.3
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
75
1.36
0.31
3.6
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
64
1.27
0.28
2.6
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
52
559
0.87
0.26
5.0
4.5
%
21.2
21.5
0.04
28
275
(40758558) Short blood count panel - Blood
24
212
1.17
0.22
12.2
6.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
11
0.00
0.21
0.0
1.3
—
89.7
—
0
11
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
274.7
—
0
7
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
12
0.00
0.21
0.0
1.0
—
7.8
—
0
6
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.2
—
438.5
—
0
6
(3011288) Drugs identified in Urine by Screen method
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
14
0.00
0.20
0.0
1.6
—
1.6
—
0
14
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
14
0.00
0.20
0.0
4.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
81
1.26
0.19
2.8
2.3
nmol/l
329.9
393.0
—
10
70
(3019060) Gas panel - Arterial blood
5
68
0.72
0.17
6.2
3.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
69
1.17
0.17
6.1
4.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
78
0.76
0.16
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
73
703
1.10
0.16
6.0
5.2
ug/l
2.1
2.8
0.82
65
626
(3000492) Spirometry study
9
79
1.15
0.15
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
180
0.87
0.14
3.9
5.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
46
1.09
0.10
3.6
4.3
mmol/l
24.6
23.6
—
5
41
(3000330) Specific gravity of Urine by Test strip
5
46
1.09
0.10
5.4
4.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
11
98
1.14
0.08
11.0
8.2
mmol/l
12.2
10.4
0.37
11
93
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
79
806
0.94
0.08
5.9
6.6
mmol/mol
41.6
41.5
0.05
67
749
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
42
404
1.06
0.07
3.8
4.2
ng/l
48.4
53.8
0.11
34
313
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
86
873
0.94
0.06
4.5
5.2
mmol/l
2.6
2.6
0.06
76
798
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
72
733
0.95
0.05
3.5
3.8
mu/l
2.0
2.1
0.15
61
651
(3012544) pH of Venous blood
11
101
1.10
0.04
5.4
4.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
56
571
0.96
0.04
3.1
3.0
pmol/l
14.1
14.9
1.52
51
501
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
86
850
1.05
0.03
4.3
4.6
mmol/l
1.2
1.3
0.90
75
775
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
20
208
0.95
0.02
2.5
1.7
mmol/l
1.9
1.5
0.93
14
176
(3029937) Albumin [Presence] in Urine by Test strip
23
238
0.96
0.02
4.5
3.9
estimate
0.0
0.0
—
9
80
(3012516) Albumin [Mass/volume] in Urine
28
288
0.96
0.02
3.9
3.3
mg/l
104.0
264.3
0.36
22
208
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
86
852
1.04
0.02
5.0
4.7
mmol/l
4.5
4.4
0.25
76
784
(40768797) Stomach Pathology biopsy report
12
113
1.07
0.02
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
302
0.99
0.00
4.9
4.2
mg/mmol
15.1
10.9
0.19
24
208
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
83
832
0.99
0.00
4.6
4.2
mmol/l
1.5
1.4
1.06
74
757
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
44
435
1.02
0.00
1.9
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
10
102
0.98
0.00
1.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
189
1.01
0.00
3.3
3.7
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
2.2
—
0
7
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
7
0.00
0.00
0.0
2.1
—
3.6
—
0
7
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.8
—
0.6
—
0
6
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
69
1.02
0.00
1.4
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
64.4
—
0
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
17.7
—
936.2
—
0
6
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
100
1.00
0.00
5.3
4.3
kpa
6.0
5.6
—
10
92
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
23.2
—
1430.2
—
0
6
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
12.8
—
0
5
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4024509)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
1.0
—
49.4
—
0
5
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
6
62
0.97
0.00
8.7
5.6
ng/l
166.0
102.6
—
6
55
(21494755) Public health laboratory ask at order entry panel
7
74
0.94
0.00
1.6
1.6
—
—
—
0
0
(4062490)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
9
0.00
0.00
0.0
1.4
—
11.4
—
0
9
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
164.2
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
60
1.00
0.00
9.3
2.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
79
1.01
0.00
5.3
3.7
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
83
0.96
0.00
5.4
3.1
kpa
5.8
4.7
—
8
75
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
61
0.98
0.00
1.8
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PENIS – Malignant neoplasm of penis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).